On the recordMay 15, 2019
I think it has found its way into litigation as to whether Gilead knew back when it was developing TDF that the TAF opportunity might be a safer one.
Source
congress.govEditor's note · Context
Sarbanes questions Gilead's knowledge about drug safety during development.
Share
More from John Sarbanes
Mar 29, 2023
I thank the chairman for yielding and recognizing me. Madam Chair, I rise in strong opposition to the Republicans' energy bill. I have deep concerns about this package overall in terms of its attack on our bedrock environmental laws. As a…
Oct 17, 2023
I hope that today's hearing is the first step in continuing that legacy of strong bipartisan support for the Chesapeake Bay in this Congress.
Apr 25, 2023
If we have a better understanding of these factors, we can address them more effectively, which will, in turn, improve patient access and care overall.
Mar 22, 2023
If you concluded that putting some reasonable limits in place and trying to find a way to enforce them would lead some percentage of your users to leave TikTok and go somewhere else, is that something that you are prepared to accept?
Other voices in this conversation
